During the past decade, Lewis Cancer and Research Pavilion at Saint Joseph's/Candler conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 130 clinical trials were completed, i.e. on average, 89.7% percent of trials that started reached the finish line to date. In the past 5 years, 53 clinical trials started and 79 clinical trials were completed. i.e. 149.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler" #1 sponsor was "National Cancer Institute (NCI)" with 100 trials, followed by "SWOG Cancer Research Network" with 41 trials sponsored, "Alliance for Clinical Trials in Oncology" with 34 trials sponsored, "NRG Oncology" with 20 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler" #1 collaborator was "National Cancer Institute (NCI)" with 159 trials as a collaborator, "NRG Oncology" with 36 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 10 trials as a collaborator and "Canadian Cancer Trials Group" with 9 trials as a collaborator. Other collaborators include 62 different institutions and companies that were collaborators in the rest 42 trials.

According to Clinical.Site data, the most researched conditions in "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler" are "Breast Cancer" (20 trials), "Stage IV Lung Cancer AJCC v8" (12 trials), "Recurrent Ovarian Carcinoma" (11 trials), "Recurrent Fallopian Tube Carcinoma" (10 trials) and "Invasive Breast Carcinoma" (9 trials). Many other conditions were trialed in "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler" in a lesser frequency.

Most popular intervention types in "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler" are "Drug" (190 trials), "Other" (151 trials), "Biological" (96 trials), "Radiation" (64 trials) and "Procedure" (61 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (71 trials), "Quality-of-Life Assessment" (62 trials), "Paclitaxel" (37 trials), "Questionnaire Administration" (36 trials) and "Carboplatin" (32 trials). Other intervention names were less common.

The vast majority of trials in "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler" are 185 trials for "All" genders, 63 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Lewis Cancer and Research Pavilion at Saint Joseph's/Candler". undefined are not yet recruiting, 52 are recruiting, 121 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 69 completed trials in Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, 3 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, 4 "Phase 1" clinical trials were conducted, 110 "Phase 2" clinical trials and 144 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 14 trials that are defined as “Not Applicable".